You Searched For "analyst report on metropolis healthcare ipo" and got 16 results
Sort By:
3 mins read
A new IPO in India has its eyes on a $12.3 billion market-- but there are many risks
Metropolis Healthcare is a leading diagnostics chain in India with presence in 197 cities in 19 s…
2 mins read
Tarsons Products IPO listing tomorrow; GMP staggers around ₹170
Indian labware company Tarsons Products is all set to list its initial public offering (IPO) on sto…
3 mins read
The IPO from Tarsons, a Bengal-based supplier for Dr Lal Path Labs and Dr Reddy’s, gets a unanimous ‘subscribe’ call from the street
Today is the second day to subscribe to the Indian labware company Tarsons Products initial public …
2 mins read
Tarsons Products makes a decent stock market debut amid weak market trend; lists at 6% premium
Shares of Indian labware company Tarsons Products made a decent listing on the National Stock Excha…
3 mins read
Lyft, Uber, and Slack are the IPOs getting all the attention this year - but a completely different corner of the market is heating up
"It's still early days for leveraging some of the newer tools, like gene therapy and RNAi, that hav…
Rebecca Ungarino
3 mins read
India needs a regulator for private hospitals and doctors, says Chief Economic Advisor
Private sector healthcare in India is considered to be superior to the public sector because it’s m…
2 mins read
The US IPO market has gone cold
Renaissance Capital published an analysis of IPO data from the first quarter of 2015, and found tha…
Jonathan Marino
6 mins read
KIMS IPO – most analysts are bullish on the hospital chain’s prospects
The KIMS IPO opens tomorrow and hopes to mop up ₹2,144 crore from the bullish share markets. It is …
1 min read
Metropolis Healthcare promoter offloads 6.03% stake for Rs 422.58 crore
The company in an exchange filing said "a member of the promoter group of the company has divested …
PTI
2 mins read
Deliveroo's IPO flopped this week. The UK startup may have waited too long to cash in on the IPO frenzy for COVID-19 'winners.'
The British food-delivery startup doesn't have the scalability of a bigger US tech company like Ube…
Shalini Nagarajan
4 mins read
Morgan Stanley says Moderna could double after the biotech's massive wipeout in 2018
Other investors have been more skeptical of Moderna's success. When sharing her 2019 predictions, V…
Lydia Ramsey,Emma Court
6 mins read
From Nykaa to Cipla to 3i infotech — these are some of the themes the market is betting on amid a sell-off
Media reports of multiple cases of the new COVID variant — B.1.1.529 — reported in countries includ…
4 mins read
Here’s why analysts believe ₹100 crore IPO of Dr Trust’s parent Nureca is a ‘sizeable’ opportunity
The ₹100 crore initial public offering (IPO) of healthcare and wellness products distributor Nureca…
4 mins read
A 29-year-old exec who worked on 2019's biggest biotech IPO told us the 2 key lessons that made it a success
After studying bioengineering as an undergraduate and earning a doctorate in cardiovascular medicin…
Emma Court
2 mins read
A Wall Street analyst's top concerns about one of the hottest healthcare IPOs of 2020
These are the top stories written by Business Insider's healthcare team for July 7.
Lydia Ramsey Pflanzer
4 mins read
Dispensed: Pharma's next big megamerger, a string of healthcare IPOs, and why the CEO of Clover Health regrets setting up shop in Silicon Valley
Simultaneously, a window for digital health and healthcare IT companies appears to be opening as we…